Benzinga | Jan 11, 2021 06:23AM EST

Microbot Medical Lists 2021 Goals

Anticipated 2021 Key Operational and Product Milestones

* Conclude animal feasibility studies on the LIBERTY Robotic System.

* Achieve design freeze for LIBERTY Robotic System by Q3 2021.

* Initiate pivotal animal study for the LIBERTY Robotic system in the second half of 2021.

* Finalize FDA pre-submission for the LIBERTY Robotic System by Q4 2021.

* Conclude EFS pre-submission in regards to the SCS with the FDA by end of Q1 2021.

* Continue to explore M&A opportunities that will enhance the Company's assets and core capabilities.

* Expand and protect the Company's global IP portfolio in global jurisdictions, which creates significant barriers to entry.

* Continue to recruit medical pioneers and thought leaders to the Company's senior leadership, Board of Directors and SAB.